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In the United States, more patients are in long-term than
in acute-care facilities. Long-term care facilities deliver
various services to persons with a range of functional
disability and disease. While some of these facilities provide
care to young as well as elderly persons and psychiatric as
well as medical care, most are nursing homes, which provide
care to the elderly. The approach to preventing infection in
nursing homes will vary with characteristics of the
population.
Infections in Long-Term Care Facilities
Infections are common in long-term care facilities (1).
Major areas of concern are endemic infections, outbreaks, and
colonization and infection of residents with antimicrobial-
drug resistant microorganisms.
The most frequent endemic infections are respiratory
tract, urinary tract, skin and soft tissue, and gastrointestinal
infections (primarily manifesting as diarrhea) (Table 1).
Respiratory tract infections include upper tract infections,
such as pharyngitis and sinusitis, and lower tract infections,
such as bronchitis and pneumonia. Pneumonia is the only
infection in this setting that is often fatal (1). Urinary tract
infections are the most frequent infections; while most
patients are asymptomatic, the prevalence rates of
bacteriuria are 25% to 50% (2). Skin and soft tissue infections
include decubitus ulcers, infected vascular or diabetic foot
ulcers, erysipelas, and other types of cellulitis. Nonbacterial
causes of skin infection include oropharyngeal or intertrigi-
nous candidiasis, as well as herpes zoster.
Many bacteria, fungi, viruses, and parasites cause
outbreaks in nursing homes (Table 2). The most common are
outbreaks of  respiratory infection caused by influenza A (3).
However, parainfluenza and respiratory syncytial viruses
also cause respiratory outbreaks. Gastrointestinal outbreaks,
including those caused by bacteria such as Escherichia coli
O157:H7 and Salmonella species, as well as small round
enteric viruses, are also common. Skin outbreaks with scabies
are frequent.
Nursing home residents are at risk for colonization with
antimicrobial drug-resistant microorganisms (1,4,5), includ-
ing methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant enterococcus (VRE), penicillin-resis-
tant Streptococcus pneumoniae, gram-negative microorgan-
isms with extended-spectrum beta-lactamases, and increas-
ingly, quinolone-resistant Enterobacteriaceae. Some U.S.
facilities have reported rates of colonization with MRSA as
high as 30% (1). Colonization with resistant microorganisms
usually occurs in the acute-care facility, and transmission
within the long-term care facility is uncommon in the
nonoutbreak situation.
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Table 1. Common endemic infections in long-term care facilities (1)
Site of infection Frequency/1,000 patient days
Urinary tract   0.46 – 4.4
Respiratory tract     0.1 – 2.4
Skin, soft tissue   <0.1 – 2.1
Gastrointestinal tract        0 – 0.9
Table 2. Microorganisms reported to cause outbreaks in long-term care
facilities (1)
Parasites
Viruses Bacteria ectoparasites
Influenza A,B Group A Streptococcus Giardia lamblia
Parainfluenza Staphylococcus aureus Entamoeba histolytica
Respiratory Streptococcus pneumoniae Sarcoptes scabiei
  syncytial
  virus
Caliciviruses Haemophilus influenzae
Adenovirus Bordetella pertussis
Rhinovirus Salmonella spp.
Coronavirus Shigella spp.
Rotavirus Campylobacter jejuni
Aeromonas hydrophila
Escherichia coli O157:H7
Clostridium perfringens
Bacillus cereus
Mycobacterium tuberculosis206 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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Considerations Unique to Long-Term Care Facilities
While the reasons for preventing infections are the same
in long-term and acute-care facilities, several considerations
relevant to prevention of infection differ in long-term care
populations (6). For most long-term care residents, the facility
is their domicile. All members of society experience infections
within their homes; to what degree are unusual measures
appropriate or realistic to prevent the usual infections in this
setting? When is it reasonable to limit mobility or social
interaction of persons in their usual residence to prevent
transmission of infection?
Long-term care residents also are often highly
functionally impaired. Many are incontinent, immobile, and
confused or demented. The worse the functional status, the
greater the likelihood of infection or colonization with
resistant microorganisms (1,4,7). For example, incontinence
and impaired mental status have consistently been
associated with asymptomatic urinary tract infection (2).
MRSA colonization is more likely to be identified in residents
with pressure ulcers or fecal incontinence or who are bed
bound or require feeding tubes or urinary catheters (7). In
most cases, impaired functional status is a determinant of
admission to long-term care and is not modifiable. If the major
predictors of infection in long-term care facilities are poor
functional status and co-existing chronic illness, and these
conditions cannot be altered, to what extent is it realistic to
anticipate that endemic infections can be prevented in such
residents? In addition, with the number and severity of
existing conditions, how much illness or death is attributable
to infections per se, rather than to underlying chronic disease?
Assessing the impact of infection on patient outcome in
evaluating interventions to prevent infection is, thus, often
problematic. An example is a decision to provide comfort care
but not to treat pneumonia with antibiotics in severely
impaired patients.
Diagnostic uncertainty is also a major issue in identifying
infections and assessing interventions to prevent them.
Standard clinical guidelines for surveillance of infection have
been developed for long-term care facilities (8), but many
barriers to diagnostic accuracy exist (9). Communication is
impaired because of dementia, blindness, or deafness, and
clinical assessment is complicated by symptoms associated
with chronic conditions, such as cough or incontinence. The
very high prevalence of asymptomatic bacteriuria means
that, in a patient with nonspecific deterioration in clinical
status, a positive urine culture has a low predictive value for
identifying symptomatic urinary infection (10). Similarly, the
high prevalence of oropharyngeal colonization with gram-
negative microorganisms indicates that isolation of Entero-
bacteriaceae from the sputum of a person with lower
respiratory tract infection has a low predictive value for
identifying the infecting microorganism (2).
Infection Control Programs
In the last 2 decades, an increasing number of long-term
care facilities have developed infection control programs with
surveillance and control activities (11,12). A major
contribution to this development was the publication of
guidelines by the Association for Professionals in Infection
Control and Epidemiology (APIC) in 1991 (13). These were
updated in 1997 as the Society for Healthcare Epidemiolo-
gists of America (SHEA)-APIC position paper on infection
prevention and control in long-term care facilities (6). The
document reviews infections in such facilities and makes
specific recommendations for a feasible and relevant control
program.
Differences between acute-care and long-term care
facilities affect the development and management of infection
control (6). Generally, long-term care facilities have fewer
resources. Part-time employees or employees with many other
responsibilities are often responsible for infection control, and
the secretarial and computer resources may be limited. The
educational level of the staff is often lower than in acute-care
facilities. Radiologic and laboratory facilities are often not on
site (9). Diagnostic tests may not be obtained because access
to such tests requires patient transfer. Return of test results
on microbiologic specimens may be prolonged. The medical
record often is inadequate and access to physician resources is
limited. As observation without intervention may be the more
appropriate management approach in some cases, this
physician shortage may lead to overuse of empiric antibiotics.
Finally, limited clinical research is available to validate
either an overall infection control program or specific
components of a program in the long-term care facility.
SHEA-APIC infection control guidelines are evidence
based (6). They categorize recommendations as A (having
good evidence to support the recommendation), B (moderate
evidence to support a recommendation), and C (poor evidence
to support the recommendation). The quality of evidence is
designated as follows: I (at least one randomized controlled
trial), II (at least one well-designed clinical trial without
randomization),  or III (opinions of respected authorities). The
infrequency of evidence designations in the guidelines
demonstrates the limitations of available research (6). Only
five recommendations are AI, BI, AII, or BII: for
handwashing, tetanus-diphtheria immunization, annual
influenza immunization, and hepatitis B and influenza
immunizations for employees. All other recommendations are
AIII or BIII, i.e., based on opinions of respected authorities.
Thus, further evaluation of the effectiveness of specific
interventions is needed.
Clinical Trials of Interventions to Prevent Infections
Results of several recent clinical trials in long-term care
settings (Table 3) have been uniformly negative with respect
to the interventions assessed but are helpful in addressing the
question of the extent to which endemic infections are
preventable in such facilities (14-17). Many other issues
relevant to specific interventions in care in long-term care
facilities require assessment, particularly with the increasing
use of invasive devices. For example, appropriate care needs
to be explored for patients with chronic tracheostomies and
respirator therapy, dialysis therapy, central lines, and
percutaneous feeding tubes to limit infections and minimize
cost.
Management of Drug-Resistant Microorganisms
Antimicrobial drug-resistant microorganisms may cause
illness and death in acute-care facility residents (1,4).
However, it is not clear that a high prevalence of colonization
with these microorganisms is associated with excess illness or
death (7). In addition, no evidence supports the use of
stringent barrier precautions to decrease illness or death from
antimicrobial drug-resistant microorganisms in long-term
care facilities (5,7). Nevertheless, such facilities have
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with drug-resistant microorganisms, and management of
patients colonized or infected with resistant microorganisms
has sometimes been inappropriate.
Observational studies suggest that the intensity of
barrier precautions, isolation or cohorting, or environmental
cleaning does not decrease the likelihood of transmission of
MRSA or VRE (7). Thus, additional precautions are
recommended for patients colonized with these microorgan-
isms only when the patients are a documented source of
transmission to other patients (4,5) (e.g., MRSA patients with
extensive skin lesions  that cannot be covered or VRE patients
with diarrhea and incontinence).
Conclusions
There are many complex, unanswered questions in the
prevention of infection in long-term care facilities. Priority
issues for evaluation include determining the most
appropriate surveillance strategies for endemic infections
and identifying outbreaks early and efficiently. Recommen-
dations for influenza A have been made (3). However, when
should cultures be obtained from patients with diarrhea?
What is appropriate surveillance for endemic infections, and
should it be focused only in areas where an opportunity for
prevention exists?
The feasibility of preventing endemic infections requires
further study. In addition, the feasibility of decreasing or
preventing high colonization rates with drug-resistant
microorganisms in long-term care facility residents needs to
be assessed, since most patients acquire these microorgan-
isms in acute-care facilities. Practices related to antimicro-
bial-drug use are key to this question. In addition to
controlled comparative trials to identify appropriate
antimicrobial-drug use, patients who do not require
treatment need to be identified. The role of drug therapy in
preventing infections is also not adequately studied. Finally,
an infection control program may be costly. What are the
benefits of such a program?  Decreased length of stay, for
example, will not usually be a meaningful outcome. Thus,
while substantial progress has been made in the past decade
in managing infection prevention, many issues still need to be
answered. As the elderly population will increase in the next
two decades, addressing these problems must be a priority.
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Table 3. Assessing effectiveness of selected interventions in decreasing
infections in long-term care facilities
Study question
(reference)                Outcome
Does vitamin A supplementation No decrease in overall
decrease the frequency of occurrence of infection with
infection? (14) vitamin A supplementation
Do outcomes differ with routine No difference in infection or
percutaneous feeding tube other relevant outcomes with
changes compared with routine tube changes
as-needed changes? (15)
Does treatment to eradicate No decrease in infection with
MRSAa colonization decrease antimicrobial therapy
the frequency of MRSA
infection? (16)
Does the frequency of No difference in frequency of
symptomatic urinary infection infection or antimicrobial use
differ with clean or sterile
intermittent catheterization?
(17)
aMRSA = methicillin-resistant Staphylococcus aureus.